Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
The Oncologist|December 1, 2011
Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?Guido Cavaletti
The Lancet. Oncology|February 1, 2011
Bortezomib-induced peripheral neuropathy: facts and genesGuido Cavaletti
The Lancet. Oncology|June 2, 2009
Chemotherapy-induced peripheral neurotoxicity: how can we improve knowledge?Guido Cavaletti
Journal of the Peripheral Nervous System : JPNS|July 1, 2014
Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we knowGuido Cavaletti
Current Medicinal Chemistry|August 22, 2006
Current status and future prospective of immunointervention in multiple sclerosisGuido Cavaletti
Nature Reviews. Cancer|December 27, 2007
Peripheral neurotoxicity of platinum-based chemotherapyGuido Cavaletti
Nature Reviews. Neurology|November 10, 2010
Chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, Paola Marmiroli
Expert Review of Neurotherapeutics|August 9, 2016
How can neuroplasticity be utilized to improve neuropathy symptoms?Arianna Scuteri, Guido Cavaletti
Mini Reviews in Medicinal Chemistry|June 13, 2009
Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivativesSante Cundari, Guido Cavaletti
Current Medicinal Chemistry|February 7, 2012
Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disordersGuido Cavaletti, Barbara Slusher
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
The Oncologist|December 1, 2011
Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?Guido Cavaletti
The Lancet. Oncology|February 1, 2011
Bortezomib-induced peripheral neuropathy: facts and genesGuido Cavaletti
The Lancet. Oncology|June 2, 2009
Chemotherapy-induced peripheral neurotoxicity: how can we improve knowledge?Guido Cavaletti
Journal of the Peripheral Nervous System : JPNS|July 1, 2014
Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we knowGuido Cavaletti
Current Medicinal Chemistry|August 22, 2006
Current status and future prospective of immunointervention in multiple sclerosisGuido Cavaletti
Nature Reviews. Cancer|December 27, 2007
Peripheral neurotoxicity of platinum-based chemotherapyGuido Cavaletti
Nature Reviews. Neurology|November 10, 2010
Chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, Paola Marmiroli
Expert Review of Neurotherapeutics|August 9, 2016
How can neuroplasticity be utilized to improve neuropathy symptoms?Arianna Scuteri, Guido Cavaletti
Mini Reviews in Medicinal Chemistry|June 13, 2009
Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivativesSante Cundari, Guido Cavaletti
Current Medicinal Chemistry|February 7, 2012
Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disordersGuido Cavaletti, Barbara Slusher
Pageof 29